Enducal, Nida P.

HRN: 15-51-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2022
CEFTAZIDIME 1GM (VIAL)
05/24/2022
05/31/2022
IV
1 Gram
Q8hrs
CAP; Presumptive PTB, Relapse
Waiting Final Action 
05/24/2022
AZITHROMYCIN 500MG TABLET (TAB)
05/24/2022
05/28/2022
500MG/TAB
500mg
OD
CAP-MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: